D-1451-2019 Class II Terminated
FDA drug recall D-1451-2019 was initiated by Zydus Pharmaceuticals USA Inc on May 6, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. The recall status is terminated (terminated Sep 16, 2021). Affected quantity: 13,564 25-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2019
- Initiation Date
- May 6, 2019
- Termination Date
- Sep 16, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,564 25-count bottles
Product description
MethylPREDNISolone Tablets, USP 32 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-919-11
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Distribution pattern
Nationwide in the USA
Code information
Lots: M713043, M713047, EXP Dec-19; M713045, EXP Nov- 19; M816143, EXP Oct-20.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1451-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026